North Central Cancer Treatment Group N0531: Phase II Trial of weekly albumin-bound paclitaxel (ABI-007; Abraxane) in combination with gemcitabine in patients with metastatic breast cancer

Clin Breast Cancer. 2005 Oct;6(4):361-4. doi: 10.3816/CBC.2005.n.042.
No abstract available

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Albumin-Bound Paclitaxel
  • Albumins / administration & dosage
  • Antimetabolites, Antineoplastic / pharmacology
  • Antineoplastic Agents, Phytogenic / pharmacology
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Breast Neoplasms / blood
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / pathology
  • Caveolin 1 / blood
  • Clinical Trials, Phase II as Topic / methods*
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / analogs & derivatives
  • Drug Administration Schedule
  • Female
  • Gemcitabine
  • Humans
  • Infusions, Intravenous
  • Middle Aged
  • Multicenter Studies as Topic / methods
  • Neoplasm Metastasis
  • Paclitaxel / administration & dosage

Substances

  • Albumin-Bound Paclitaxel
  • Albumins
  • Antimetabolites, Antineoplastic
  • Antineoplastic Agents, Phytogenic
  • Caveolin 1
  • Deoxycytidine
  • Paclitaxel
  • Gemcitabine